What was FEM-PrEP?
Publications
Early Closure Fact Sheets

Investigators, staff, and collaborators
Contact Information
Related Research & Information

A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya and Pretoria, South Africa

Publications

Participants’ explanations for non-adherence in the FEM-PrEP clinical trial

PubMed
Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: A new measure of antiretroviral adherence?
Facilitators of adherence to the study pill in the FEM-PrEP clinical trial

Related Research & Information

FHI 360 and others are currently or have recently conducted complementary research on ARV-based HIV prevention products.
Read more